Stock Movers

On today's episode of Stock Movers:

- Shares of PayPal (PYPL) rose after a report suggested that its days as a standalone public company may be numbered, with its stock being described as "deeply undervalued" The company has fielded meetings with banks amid unsolicited interest from suitors, with at least one large rival looking at the whole company and others interested in certain PayPal assets.

- American Express (AXP) dragged the Dow Jones Industrial Average lower on Monday afternoon as investors responded to a bleak 2027 AI-driven recession scenario published by Citrini Research, a firm that offers thematic and global macro trading ideas.

- Domino’s Pizza Inc. shares jumped after the company reported a larger-than-expected rise in comparable sales, as consumers were drawn to the pizza chain’s budget-friendly pies. Domino’s US same-store sales for the fourth quarter rose 3.7% in the quarter, above the 3.3% increase projected by analysts, fueled by demand for its stuffed crust pizzas and its “Best Deal Ever” pizza promotion
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Emily Graffeo.

- IBM (IBM) shares plunged on Monday, after the artificial intelligence startup Anthropic said its Claude Code tool can help with modernizing COBOL, a dated programming language that’s mainly run on IBM computers. Shares sank 13% in their biggest one-day percentage loss since October 2000. With the decline, the stock is now down 27% in February, on track for its biggest one-month percentage decline since at least 1968, according to data compiled by Bloomberg.

-Arcellx (ACLX) shares surge as much as 78% — a record — to an all-time high after Gilead Sciences agreed to acquire the biotech company for $115 per share in cash and one contingent value right of $5 per share. Stifel views the deal as a “a near-term better-case scenario” for Arcellx.

DoorDash (DASH) stock slid Monday as investors reacted to a viral post from a research group describing the food-delivery company as a "poster child" for risks from AI agents. A company cofounder responded on X after the report sparked debate on the social media platform over the weekend.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Deere (DE) shares fall after Jefferies downgraded the company, saying the stock is pricing in a rebound in the farm economy that appears “elusive.” A downturn should reach its worst point this year, but analyst Stephen Volkmann says troughs have lasted years in the past and farmers face high costs and a volatile trade environment.
- Veris Residential (VRE) shares climb the most intraday since July 2023, after saying it will be acquired by an investor consortium led by Affinius Capital in partnership with Vista Hill Partners, in an all-cash transaction for $19 per share.
- Vanda Pharmaceuticals (VNDA) shares surge after the US FDA approved the firm’s oral medication for treating manic or mixed episodes in bipolar I disorder and schizophrenia in adults.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Novo Nordisk (NVO) shares sink after its' next-generation obesity shot CagriSema delivered less weight loss than Eli Lilly & Co.’s rival blockbuster tirzepatide in a head-to-head trial.
- Domino's Pizza (DPZ) shares rise after the company reported a larger-than-expected rise in comparable sales, as consumers were drawn to the pizza chain’s budget-friendly pies. The Ann Arbor, Michigan-based company made more money by selling more food to its stores, charging higher prices for ingredients and collecting more fees from franchise operators for advertising and royalties, it said in a Monday statement.
- International Paper (IP) shares fall as analysts note that a surprise price drop in domestic containerboard is negative for US packaging companies.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Gilead Sciences Inc. agreed to buy US cancer-focused biotech Arcellx Inc. for as much as $7.8 billion as it seeks to boost its drug pipeline. Gilead, which owns 11.5% of Arcellx’s outstanding stock, will pay $115 per share in cash, with a contingent payment of $5 per share dependent on future sales, it said Monday. The price is almost double Arcellx’s Friday closing price. Shares of Arcellx rose as much as 78% to $114.18 in premarket trading in New York, while Gilead’s stock slipped about 0.6%.
- Novo Nordisk A/S’s next-generation obesity shot delivered less weight loss than Eli Lilly & Co.’s rival blockbuster in yet another blow to the Danish company’s attempts to regain lost ground in the weight-loss market. People treated with a standard dose of Novo’s CagriSema in a trial achieved 20.2% weight loss after 84 weeks, compared with 23.6% for Lilly’s tirzepatide. Novo’s shares plunged as much as 16.5% in Copenhagen on Monday, while Lilly shares rose as much as 4.2% in premarket US trading.
- Domino's Pizza posted another quarter with strong comparable-sales growth and new restaurant openings, which sent the stock higher Monday. Still, shares have been trading at their lowest levels in more than two years as investors remain cautious about the restaurant sector. For the fourth quarter ended in December, the pizza chain grew its net revenue by 6.4% from a year ago to $1.54 billion, beating Wall Street's consensus expectations of $1.52 billion. Earnings came in at $5.35 per share, up 9.4% from a year earlier, but slightly below the expected $5.38, the company said Monday.
See omnystudio.com/listener for privacy information.